ACTIVE LEARNING TEMPLATE: Medication
Yvonne Trang
STUDENT NAME _____________________________________
Prednisone
MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________
17
Oral Glucocorticoid
CATEGORY CLASS ______________________________________________________________________
PURPOSE OF MEDICATION
Expected Pharmacological Action Therapeutic Use
Prevents inflammation, suppresses airway Decreased fre uency and se rity of
mucus production, and promotes exacerbations and acute asthma attacks
responsiveness of beta2 receptrs in the
bronchial tree. Reduces airway mucosa
Complications Medication Administration
-Difficulty speaking hoarseness and candidiasis -Administer using an MDI, DPI,
- sage of >10 days can cause supression of adrenal gland or nebulizer
function (inability to produce glucocorticoids) -Use oral glucocorticoiuds short-
-Bone loss, hyperglycemia, and glycosuria term
Contraindications/Precautions
-Pregnancy Risk ategory D
- ontraindicated in patients ho has recei d a li rus
ccine and those ith a systemic fungal infection Nursing Interventions
- se cautiously in children patients ith dia etes mellitus - reat patient s candidiasis ith
hypertension peptic ulcer disease osteoporosis nystatin oral suspension
- minister on an alternate-day
dosing schedule to pre nt
adrenal gland problems and
Interactions
bone loss
-Potassium-depleting diuretics (increases risk of - nitor blood glucose le ls
hypokalemia)
-NSAIDs (increases risk of GI ulceration)
-Glucocorticoids and hypoglycemic agents
Client Education
inse mouth after use
nitor for redness, sores, or
Evaluation of Medication Effectiveness hite patches
- ong-term control of asthma o T stop abruptly
- esolution of acute exacerbation (no shortness of breath, Perform weight-bearing
clear breath sounds, no hee ng, and return of to exercises
baseline)
ACTIVE LEARNING TEMPLATES
Yvonne Trang
STUDENT NAME _____________________________________
Prednisone
MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________
17
Oral Glucocorticoid
CATEGORY CLASS ______________________________________________________________________
PURPOSE OF MEDICATION
Expected Pharmacological Action Therapeutic Use
Prevents inflammation, suppresses airway Decreased fre uency and se rity of
mucus production, and promotes exacerbations and acute asthma attacks
responsiveness of beta2 receptrs in the
bronchial tree. Reduces airway mucosa
Complications Medication Administration
-Difficulty speaking hoarseness and candidiasis -Administer using an MDI, DPI,
- sage of >10 days can cause supression of adrenal gland or nebulizer
function (inability to produce glucocorticoids) -Use oral glucocorticoiuds short-
-Bone loss, hyperglycemia, and glycosuria term
Contraindications/Precautions
-Pregnancy Risk ategory D
- ontraindicated in patients ho has recei d a li rus
ccine and those ith a systemic fungal infection Nursing Interventions
- se cautiously in children patients ith dia etes mellitus - reat patient s candidiasis ith
hypertension peptic ulcer disease osteoporosis nystatin oral suspension
- minister on an alternate-day
dosing schedule to pre nt
adrenal gland problems and
Interactions
bone loss
-Potassium-depleting diuretics (increases risk of - nitor blood glucose le ls
hypokalemia)
-NSAIDs (increases risk of GI ulceration)
-Glucocorticoids and hypoglycemic agents
Client Education
inse mouth after use
nitor for redness, sores, or
Evaluation of Medication Effectiveness hite patches
- ong-term control of asthma o T stop abruptly
- esolution of acute exacerbation (no shortness of breath, Perform weight-bearing
clear breath sounds, no hee ng, and return of to exercises
baseline)
ACTIVE LEARNING TEMPLATES
